+441.7%
SPMO vs CVE
+129.1%
+312.6%
-30.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | +0.1% | -0.7% | -0.6% |
| 7D | -1.8% | +2.1% | -3.9% | -2.1% |
| 30D | -9.7% | -14.2% | +4.6% | -7.8% |
| 3M | -17.8% | -11.7% | -6.2% | -16.6% |
| 6M | -11.0% | -7.4% | -3.6% | -10.5% |
| YTD | +7.3% | +69.8% | -62.4% | -1.6% |
| 1Y | +10.2% | +59.8% | -49.6% | +1.9% |
| 3Y | +110.8% | +68.9% | +42.0% | +90.5% |
| 5Y | +106.6% | +154.3% | -47.6% | +74.5% |
| 10Y | +441.7% | +134.3% | +307.4% | +290.7% |
| All | +441.7% | +129.1% | +312.6% | +290.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling